Company: MBIO
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001410578-25-000028
Chunk: 88

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-15
Form: S-1
Chunk 88
---
 or other comparable terminology. In addition, statements that “we believe” or similar statements reflect our beliefs and opinions on the relevant subject. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed in, or implied by these, forward-looking statements and therefore, you should not unduly rely on such statements, including, but not limited to:

| ● | expectations for increases or decreases in expenses; |

| ● | expectations for the clinical and pre-clinical development, manufacturing, regulatory approval, and commercialization of our pharmaceutical product candidates or any other products we may acquire or in-license; |

| ● | use of clinical research centers and other contractors; |

| ● | expectations for incurring capital expenditures to expand our research and development and manufacturing capabilities; |

| ● | expectations for generating revenue or becoming profitable on a sustained basis; |

| ● | expectations or ability to enter into marketing and other partnership agreements; |

| ● | expectations or ability to enter into product acquisition and in-licensing transactions; |

| ● | expectations or ability to build our own commercial infrastructure to manufacture, market and sell our product candidates, if approved; |

| ● | expectations for the acceptance of our product candidates, if approved, by doctors, patients or payors; |

| ● | ability to compete against other companies and research institutions; |

| ● | our ability to attract, hire and retain qualified personnel, including the impact of our recently announced reduction in force; |

| ● | ability to secure adequate protection for our intellectual property; |

| ● | ability to attract and retain key personnel; |

| ● | ability to obtain reimbursement for our products, if approved; |

| ● | estimates of the sufficiency of our existing cash and cash equivalents and investments to finance our operating requirements, including expectations regarding the value and liquidity of our investments; |

| ● | stock price and the volatility of the equity markets; |

| ● | expected losses; and |

| ● | expectations for future capital requirements. |

57

We have based these forward-looking statements largely on our current expectations, estimates, forecasts, and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, and financial needs. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. Although we believe that we have a reasonable basis for each forward-looking statement contained in this prospectus, we cannot guarantee that the future results,